![Recent advances in cancer immunotherapy based in immune checkpoint inhibitors Recent advances in cancer immunotherapy based in immune checkpoint inhibitors](https://blog.bjbms.org/wp-content/uploads/2017/06/merkel_cell_pdl1-326x245.jpg)
News
Recent advances in cancer immunotherapy based in immune checkpoint inhibitors
Targeted therapy based on the immune checkpoint inhibitors (Anti-PD1/PD-L1) has revolutionized cancer treatment and outcome of several solid and hematologic malignancies, including non-small cell lung carcinoma (NSCLC), metastatic renal cell carcinoma, metastatic malignant melanoma, advanced/metastatic […]